Rights and permissions
About this article
Cite this article
Infant rotavirus vax would be “very cost-effective” for Armenia. Pharmacoecon. Outcomes News 640, 6 (2011). https://doi.org/10.2165/00151234-201106400-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106400-00016